Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1993;24:2023-2029

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuluz, J. W.
Right arrow Articles by Watson, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuluz, J. W.
Right arrow Articles by Watson, B. D.

Stroke, Vol 24, 2023-2029, Copyright © 1993 by American Heart Association


ARTICLES

The effect of nitric oxide synthase inhibition on infarct volume after reversible focal cerebral ischemia in conscious rats

JW Kuluz, RJ Prado, WD Dietrich, CL Schleien and BD Watson
Department of Pediatrics, University of Miami School of Medicine, Fla. 33101.

BACKGROUND AND PURPOSE: Previous in vitro and in vivo studies of the effects of nitric oxide synthase inhibition in the central nervous system have yielded conflicting results concerning the role of nitric oxide in the events that lead to ischemic injury. In this study, we tested the hypothesis that preischemic inhibition of nitric oxide synthase increases infarct volume after reversible focal cerebral ischemia in rats. METHODS: NG-nitro-L-arginine methyl ester hydrochloride 15 mg/kg IV or an equivalent volume of saline was administered to adult Wistar rats 15 minutes before middle cerebral artery occlusion by the intraluminal suture method. After 2 hours of ischemia, the suture was withdrawn, and rats were allowed to survive for 3 days. Areas of infarction in 10 hematoxylin-eosin-stained sections were measured and used to determine infarct volume. RESULTS: Administration of NG-nitro-L-arginine methyl ester hydrochloride increased hemispheric infarct volume by 137% over control (60.9 +/- 30.5 to 144.3 +/- 19.6 mm3, P < .05; mean +/- SEM). Cortical and subcortical infarct volumes were increased by 176% (33.8 +/- 21.9 to 93.3 +/- 15.2 mm3, P < .05) and 103% (25.1 +/- 9.4 to 51.0 +/- 5.5 mm3, P < .03), respectively. CONCLUSIONS: Nitric oxide synthase inhibition increases infarct volume and decreases the variability of the response to middle cerebral artery occlusion in Wistar rats, a strain that is normally resistant to focal cerebral ischemic injury owing to extensive collateralization. The mechanism of the deleterious effect of nitric oxide synthase inhibition likely involves a more severe degree of blood flow reduction during and after middle cerebral artery occlusion, primarily by preventing the vasodilatory response of collateral vessels to proximal middle cerebral artery occlusion. Maintenance of nitric oxide synthase activity during and after focal cerebral ischemia appears to minimize ischemic injury.


This article has been cited by other articles:


Home page
Anesth. Analg.Home page
J. C. Drummond, L. D. McKay, D. J. Cole, and P. M. Patel
The Role of Nitric Oxide Synthase Inhibition in the Adverse Effects of Etomidate in the Setting of Focal Cerebral Ischemia in Rats
Anesth. Analg., March 1, 2005; 100(3): 841 - 846.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. A. Coert, R. E. Anderson, and F. B. Meyer
Is neuroprotective efficacy of nNOS inhibitor 7-NI dependent on ischemic intracellular pH?
Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H151 - H159.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. A. Kidd, L. W. Dobrucki, V. Brovkovych, D. F. Bohr, and T. Malinski
Nitric Oxide Deficiency Contributes to Large Cerebral Infarct Size
Hypertension, May 1, 2000; 35(5): 1111 - 1118.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Takada, K. Yamashita, Y. Sakurai-Yamashita, K. Shigematsu, Y. Hamada, K. Hioki, and K. Taniyama
Participation of Nitric Oxide in the Mucosal Injury of Rat Intestine Induced by Ischemia-Reperfusion
J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 403 - 407.
[Abstract] [Full Text]


Home page
PediatricsHome page
R. C. Vannucci and J. M. Perlman
Interventions for Perinatal Hypoxic-Ischemic Encephalopathy
Pediatrics, December 1, 1997; 100(6): 1004 - 1114.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Taraska and K. T. Finnegan
Nitric Oxide and the Neurotoxic Effects of Methamphetamine and 3,4-Methylenedioxymethamphetamine
J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 941 - 947.
[Abstract] [Full Text]


Home page
StrokeHome page
K. Abe, M. Aoki, J. Kawagoe, T. Yoshida, A. Hattori, K. Kogure, and Y. Itoyama
Ischemic Delayed Neuronal Death : A Mitochondrial Hypothesis
Stroke, August 1, 1995; 26(8): 1478 - 1489.
[Abstract] [Full Text]


Home page
StrokeHome page
N. W. Knuckey, D. Palm, M. Primiano, M. H. Epstein, and C. E. Johanson
N-Acetylcysteine Enhances Hippocampal Neuronal Survival After Transient Forebrain Ischemia in Rats
Stroke, February 1, 1995; 26(2): 305 - 311.
[Abstract] [Full Text]